--

Dr Anton Borg has over 21 years experience as a consultant Haematologist. He undertook his postgraduate training at Manchester Royal Infirmary and University College Hospital, London and was also awarded a Leukaemia Research Fund Clinical Fellowship. His practice focuses in all aspects of red and white blood cell and platelet disorders, thrombosis and haemochromatosis.

Dr. Borg has a special interest in blood cell cancer, such as leukaemia, lymphoma, myeloma and myelodysplastic syndromes. He has successfully developed and introduced several chemotherapy treatments for lymphoma and leukaemia patients delivered as day-patient rather than in-patient care. He was awarded the Lymphoma Association Beacon of Hope, the Rigby Research Award to develop outpatient treatment for patients with acute myeloid leukaemia and aggressive myelodysplastic syndrome, and the Day Unit won the Royal College of Nursing award for cancer care.

In addition to his sucessful practice, Dr. Borg is active in research and conducts local research and is the local PI for some clinical trials.